Bliretrigine

Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain[1][2][3].

Product Specifications

CAS Number

[1233229-75-8]

UNSPSC

12352005

Target

Sodium Channel

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/bliretrigine.html

Purity

99.42

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

CCN1C2=CC(OC3=CC=C(C=C3)C)=CC=C2N=C1CN[C@@H](C)C(N)=O

Molecular Formula

C20H24N4O2

Molecular Weight

352.43

References & Citations

[1]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.|[2]Yoshihiro OYAMADA, et al. External medicinal preparation containing N2-{[1-ethyl-6- (4-methylphenoxy) -1H-benzimidazol-2-yl]methyl}-L-alanineamide for treating and/or preventing peripheral neuropathic pain. Patent AU2019306705.|[3]Hironori Kinoshita, et al. Preparation of N2-[ (benzimidazol-2-yl or imidazo[4,5-b]pyridin-2-yl) methyl]amino acid amide derivatives as inhibitors of sensory neuron specific sodium channel (SNS) . Patent AU2009331179.